Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas (Q34293438)

1 August 2017

1 reference

title

Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas (English)

1 reference

1 August 2017

Erlanson M

1

1 reference

PubMed ID

11426519

1 August 2017

Landberg G

series ordinal

2

1 reference

PubMed ID

11426519

1 August 2017

language of work or name

1 reference

1 February 2001

1 reference

1 August 2017

1 reference

1 August 2017

40

1 reference

1 August 2017

461-470

1 reference

1 August 2017

5-6

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

1 August 2017

1 reference

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Loss of tumor suppressor gene expression in high-grade but not low-grade non-Hodgkin's lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

p27(kip1) acts as a downstream effector of and is coexpressed with the beta1C integrin in prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109097645

10.3109/10428190109097645

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11426519